Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
09/2006
09/13/2006EP1343808B1 Process for the synthesis of an lhrh peptide
09/13/2006EP1282643B1 Anti-inflammatory compounds and uses thereof
09/13/2006CN1833171A Modulating the interaction between hgf beta chain and c-met
09/13/2006CN1832962A Preparation of somatostatin peptides
09/13/2006CN1832960A Immunomodulating compositions, uses therefor and processes for their production
09/13/2006CN1831004A Antiviral polypeptide from Zongdian Tuanwa frog and its application in pharmacy
09/13/2006CN1831003A Polypeptide organic compounds and application in xenogeneic transplantation
09/13/2006CN1831002A Synthesis of novel adenosine polypeptide compounds, and 99Tcm, 186Re tag and tag, and application in tumor treating medicines
09/13/2006CN1831000A Synthesis of novel imurel substituted peptide compounds, and 99Tcm, 186 Re tagging, and tumor medicine, anoxic imaging agent
09/13/2006CN1830989A Novel adenine polypeptide compounds synthesis and 99Tcm, 186Re tagging and the tag used in tumor and anoxic visulization
09/13/2006CN1274715C Memno peptides, a process for their preparation and their use
09/12/2006US7105641 Immunoglobulin for binding monocyte chemoattractant protein-1(MCP-1) and preventing and/or treating atherosclerosis and cancer ; antitumor agents
09/08/2006WO2006093277A1 Soybean transformant having functional peptide therein and use of the same
09/08/2006WO2006093222A1 Inhibitor for insulin polymer formation
09/08/2006WO2006092640A1 Antiproliferative peptides containing the motif phe-trp-leu, pharmaceutical compositions and medical uses thereof
09/08/2006WO2006092230A2 Protein-binding camptothecin peptide derivatives and medicaments comprising the same
09/08/2006WO2006063723A3 High-throughput enzyme-linked immuno absorbent assay (ht-elisa) for identifying r rho-kinase (rok) modulator
09/08/2006WO2006023211A3 Antigens targeted by pathogenic ai4 t cells in type 1 diabetes and uses thereof
09/08/2006CA2599743A1 A method for identifying hair conditioner-resistant hair-binding peptides and hair benefit agents therefrom
09/08/2006CA2599740A1 A method for identifying skin care composition-resistant skin-binding peptides
09/08/2006CA2599297A1 Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity
09/08/2006CA2599240A1 Fgf growth factor analogs
09/08/2006CA2599016A1 Compositions and methods for topical application and transdermal delivery of an oligopeptide
09/08/2006CA2598833A1 Anti-angiogenic compounds
09/07/2006US20060199771 Stereoselective antifibrillogenic peptides and peptidomimetics thereof
09/07/2006US20060199770 Functionalized carbon nanotubes, a process for preparing the same and their use in medicinal chemistry
09/07/2006US20060199768 Inhibitors of RecA activities for control of antibiotic-resistant bacterial pathogens
09/07/2006DE102005009784A1 Peptid-Mimetika und ihre Verwendung als Inhibitoren des 20S Proteasoms, 26S Proteasoms und Immunoproteasoms Peptide mimetics and their use as inhibitors of the 20S proteasome, the 26S proteasome and immunoproteasome
09/06/2006EP1698629A2 Polyamines and their use in therapy
09/06/2006EP1698347A2 hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
09/06/2006EP1698345A2 Peptide antagonists of zonulin and methods for use of the same
09/06/2006EP1697400A1 Biphenyl-substituted antibacterial macrocycles
09/06/2006EP1697399A2 A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1
09/06/2006EP1696945A1 Self-assembling peptide amphiphiles and related methods for growth factor delivery
09/06/2006EP1696944A2 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof
09/06/2006EP1257568B9 Novel echinocandin derivatives, preparation method and use thereof as fungicides
09/06/2006EP1214350B1 Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (dcm)
09/06/2006CN1829735A Imaging agents
09/06/2006CN1829734A Peptides capable of binding to titanium, silver and silicone
09/06/2006CN1827639A 新的细胞因子zalpha11配体 New cytokine zalpha11 Ligand
09/06/2006CN1827637A Antibacterial polypeptide from Amolops loloensis and its pharmaceutical use
09/06/2006CN1827636A Protective polypeptide of human influenza A virus, its use, vaccine and diagnostic tool
09/05/2006US7101972 With binding specificity for target nucleotides containing one or GNN triplets; regulating gene expression
09/05/2006US7101967 Drug delivery; peptide carrier is linked via oligonucleotides, nucleotides, proteins, or peptides to drugs (anticancer agents, antitumor agents- paclitaxel and/or popdphyllotoxin)
09/05/2006US7101966 Selection of peptide ligands specific for baculovirus DNA-binding protein from the FliTrx™ random peptide display library
09/05/2006US7101964 Vancomycin derivatives provide enhanced antibacterial activity, selectivity and reduced mammalian toxicity
09/05/2006US7101851 IgE receptor antagonists
09/05/2006US7101848 Bicyclic oligopeptides
09/05/2006US7101844 Amino acid sequence with cell membrane transduction potential; higher than conventional protein transduction, remains in the cytoplasm
09/05/2006US7101841 Shutting off recognition between cells by competitive binding inhibition; diagnosis of early stage cancer; inflammation, immune disease and cancer metastasis treatment; kits
09/05/2006US7101700 Peptide vector
09/05/2006US7101667 Lanthanide binding tags
09/05/2006US7101664 Using short chained amino acid sequences to increase yield of preferential cell products in animal or plant cultures; bioreactors
09/05/2006CA2143642C Immunoreactive peptides from epstein-barr virus
08/2006
08/31/2006WO2006090813A1 Element retained in blood showing degradability selectively in tumor tissue
08/31/2006WO2006089364A1 Peptide networks
08/31/2006WO2006048452A3 Peptides for use in treating of obesity
08/31/2006WO2006048450A3 Peptides for use in the treating obesity
08/31/2006WO2006038206A3 Compounds that modulate trh actions and inhibit the trh-degrading enzyme
08/31/2006WO2006024694A3 Peptide inhibitors of hk2 and their use
08/31/2006US20060194739 Nociceptin-based analgesics
08/31/2006US20060194737 Hepta-, octa-and nonapeptides having antiangiogenic activity
08/31/2006US20060194736 Polypeptide for the treatment of cancer and a method for preparation thereof
08/31/2006US20060194714 Novel depsipeptides and process for preparing same
08/31/2006US20060194340 Also, utilization of mass spectrometry (e.g., Surface Enhanced Laser Desorption Ionization, Maldi Qq TOF, MS/MS, TOF TOF, ESI-Q-TOF or ION-TRAP) to elucidate particular indicative or predictive biopolymer markers
08/31/2006US20060194338 Characterizing the existence of a disease state; particularly to the utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state
08/31/2006US20060194258 Polypeptide array synthesis
08/31/2006US20060193847 Peptides for inhibiting retroviruses
08/31/2006US20060193829 Binding molecules for human factor VIII and factor VIII-like proteins
08/31/2006US20060193778 Receptor-mediated uptake of peptides that bind the human transferrin receptor
08/31/2006US20060193773 Peptide-based compounds for use as targeting vectors that bind to receptors associated with angiogenesis; may thus be used for diagnosis or therapy of, for example, malignant diseases, heart diseases, endometriosis, inflammation-related diseases, rheumatoid arthritis and Kaposi's s sarcoma
08/31/2006DE102005009099A1 New camptothecin-peptide derivatives, useful for treating cancer
08/31/2006DE102005009084A1 New anthracyclin-peptide derivatives, useful for treating cancer, especially of the prostate, are cleaved, in the tumor, by prostate-specific antigen to release active antitumor agent and are transported by serum albumen
08/31/2006CA2597743A1 Peptide networks
08/30/2006EP1696038A2 Isolating biological modulators from biodiverse gene fragment libraries
08/30/2006EP1696037A2 Isolating biological modulators from biodiverse gene fragment libraries
08/30/2006EP1696027A1 Hla-dr-binding antigen peptide derived from wt1
08/30/2006EP1695970A1 Peptides useful for competitive modulation of dipeptidyl peptidase IV catalysis
08/30/2006EP1695718A2 Biodegradable polyester and Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
08/30/2006EP1694696A1 Delivery peptides ,their constructs with active agents and use
08/30/2006EP1694347A2 Glycopegylated erythropoietin
08/30/2006EP1210430B1 Muc-1 derived peptides
08/30/2006EP1155034B1 Formation and anion-exchange of inner crystalline echinocandin b ammonium salts
08/30/2006EP1137663B1 Purification of echinocandin cyclopeptide compounds
08/30/2006EP0980526B1 Inhibitors of nuclear protein/nuclear receptor interaction
08/30/2006EP0529033B1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof
08/30/2006CN1826354A Methods for preventing and treating alzheimer's disease (AD)
08/30/2006CN1826353A Novel melanocortin receptor templates, peptides, and use thereof
08/30/2006CN1272341C Peptide purification
08/29/2006US7098318 A carboxy terminal peptide fragment of thrombopoietin is fused with the carboxy terminal of human erythropoietin; highly enhanced in vivo half-life due to increased carbohydrate content; no antigenicity
08/29/2006US7098308 Pentapeptide compounds and uses related thereto
08/29/2006US7098307 Neo-tryptophan
08/29/2006US7098306 Method and compositions for treating hepatocellular cancer
08/29/2006US7098305 Sustained release of microcrystalline peptide suspensions
08/29/2006US7098304 Peptides that bind antibodies that are found in elevated levels in body fluids of schizophrenic patients and are found at a lower level or not found at all in body fluids of non-schizophrenic individuals
08/29/2006US7098303 Immunogenic polypeptide; vaccine for therapy of HCV infection and assays for the diagnosis of HCV
08/29/2006US7098028 Preparing in vitro cell cultures utilizing self assembling macroscopic membranes for use as slow-diffusion drug delivery systems, artificial skin, separation matrices and animal model for alzheimer's and viral diseases
08/29/2006US7097839 A conjugated compound contains antibody or a Fab, and a radiostable therapeutic active agent; for diagnosis/therapy of colorectal cancer; biological conjugated drugs
08/29/2006US7097824 Diagnosis images
08/25/2006CA2516959A1 Method for measuring spinorphin